Moleculin Biotech, Inc. (MBRX) Shareholders’ equity 2016–2025
Moleculin Biotech, Inc. (MBRX) shareholders’ equity at each fiscal year-end, per SEC filings.
$15.0MFY2025 · since FY2016: $15.0M → $15.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $15.0M | +33.9% |
| FY2024 | $11.2M | -63.8% |
| FY2023 | $30.9M | -40.7% |
| FY2022 | $52.2M | -33.9% |
| FY2021 | $79.0M | +344.8% |
| FY2020 | $17.8M | +14.1% |
| FY2019 | $15.6M | +9.1% |
| FY2018 | $14.3M | -16.6% |
| FY2017 | $17.1M | +14.4% |
| FY2016 | $15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice